Ensayos clínicos

8.676 ensayos encontrados

ReclutandoFase 3ClinicalTrials.gov

A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

INTERVENTIONALInicio: 28 de jun de 2023ID: NCT05878769

ReclutandoFase 3ClinicalTrials.gov

An 18-month, Open-label, Single-arm Safety Extension Study of an age-and Bodyweight-adjusted Oral Finerenone Regimen, in Addition to an ACEI or ARB, for the Treatment of Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

INTERVENTIONALInicio: 8 de nov de 2022ID: NCT05457283

ReclutandoClinicalTrials.gov

Prospective Urban Rural Epidemiology Study

OBSERVATIONALInicio: 1 de ene de 2002ID: NCT03225586

ReclutandoFase 3ClinicalTrials.gov

A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes

INTERVENTIONALInicio: 19 de may de 2025ID: NCT06972472

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Randomised, Placebo-controlled, Event-driven Study to Evaluate the Effect of Baxdrostat in Combination With Dapagliflozin Compared With Dapagliflozin Alone on the Risk of Incident Heart Failure and Cardiovascular Death

INTERVENTIONALInicio: 14 de mar de 2025ID: NCT06677060

ReclutandoFase 3ClinicalTrials.gov

A Prospective, Open-label, Multicenter, Randomized Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Renal Allograft Recipients Aged 12 to Less Than 18 Years of Age to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

INTERVENTIONALInicio: 21 de jul de 2021ID: NCT04877288

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Open-label Study of Belzutifan + Zanzalintinib Versus Cabozantinib in Participants With Advanced RCC Who Experienced Disease Recurrence During or After Prior Adjuvant Anti-PD-1/L1 Therapy (LITESPARK-033)

INTERVENTIONALInicio: 26 de nov de 2025ID: NCT07227402

ReclutandoClinicalTrials.gov

Long-term Risk of Recurrent Cervical Artery Dissection After Pregnancy (LONG-RECAP Study)

OBSERVATIONALInicio: 1 de ene de 2023ID: NCT06258109

ReclutandoClinicalTrials.gov

Clinical Feasibility Evaluation of the Gentuity HF-OCT Imaging System With Vis-M Micro-Imaging Catheter

INTERVENTIONALInicio: 13 de feb de 2023ID: NCT06078878

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, and Type 2 Diabetes

INTERVENTIONALInicio: 15 de dic de 2025ID: NCT07282600

ReclutandoFase 4ClinicalTrials.gov

A Phase 4, Multicenter, Prospective, Open-Label Study Describing the Efficacy and Safety of Belimumab Administered Subcutaneously in Adult Participants With Early Systemic Lupus Erythematosus

INTERVENTIONALInicio: 6 de jun de 2024ID: NCT06411249

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atumelnant in Adult Participants With Classic Congenital Adrenal Hyperplasia (Calm-CAH)

INTERVENTIONALInicio: 11 de dic de 2025ID: NCT07144163

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multi-Center Study Consisting of a Randomized, Double-Blind, Placebo-Controlled Period, Followed by an Open-Label Extension Period, to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Systemic Sclerosis

INTERVENTIONALInicio: 6 de feb de 2025ID: NCT06843239

ReclutandoFase 1ClinicalTrials.gov

A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of GSK5764227 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

INTERVENTIONALInicio: 30 de sept de 2024ID: NCT06551142

ReclutandoClinicalTrials.gov

Automatic Detection of Dyspnea in Mechanically Ventilated, Critically Ill Patients

OBSERVATIONALInicio: 22 de nov de 2024ID: NCT07205952

ReclutandoClinicalTrials.gov

Frequency of Selected Single Nucleotide Polymorphisms in Phase With the Mutant and Wild-Type HTT Alleles in Huntington Disease Gene Expansion Carriers

OBSERVATIONALInicio: 2 de sept de 2024ID: NCT06667414

ReclutandoClinicalTrials.gov

Institutional Registry of Amyloidosis (Hospital Italiano de Buenos Aires)

OBSERVATIONALInicio: 1 de abr de 2011ID: NCT01347047

ReclutandoClinicalTrials.gov

Argentine Registry of Crohn's Disease and Ulcerative Colitis

OBSERVATIONALInicio: 14 de jul de 2023ID: NCT07155148

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated With Mild to Moderate Alzheimer's Disease (MINDSET 1)

INTERVENTIONALInicio: 14 de jul de 2025ID: NCT06976216

ReclutandoFase 3ClinicalTrials.gov

A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)

INTERVENTIONALInicio: 13 de sept de 2022ID: NCT05531565